Arcturus Therapeutics Holdings, Inc. (ARCT)
11.00
-1.15
(-9.47%)
USD |
NASDAQ |
Oct 30, 16:00
11.00
0.00 (0.00%)
After-Hours: 18:10
Arcturus Therapeutics Holdings Cash and Short Term Investments (Annual) : 230.91M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 230.91M |
| December 31, 2024 | 292.03M |
| December 31, 2023 | 347.00M |
| December 31, 2022 | 391.88M |
| December 31, 2021 | 370.49M |
| December 31, 2020 | 462.90M |
| December 31, 2019 | 71.35M |
| December 31, 2018 | 36.71M |
| Date | Value |
|---|---|
| December 31, 2017 | 48.74M |
| December 31, 2016 | 8.345M |
| December 31, 2015 | 50.84M |
| December 31, 2014 | 21.70M |
| December 31, 2013 | 50.10M |
| December 31, 2012 | 13.10M |
| December 31, 2011 | 0.572M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 819.69M |
| Emergent BioSolutions, Inc. | 209.10M |
| Exelixis, Inc. | 1.059B |
| Ionis Pharmaceuticals, Inc. | 2.677B |
| United Therapeutics Corp. | 2.920B |